Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹274Cr
Rev Gr TTM
Revenue Growth TTM
13.60%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

RADIXIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -11.6 | 142.7 | 115.1 | -15.7 | -12.9 | -1.8 | 35.6 | 92.4 | 54.9 | 15.2 | -9.3 | 11.5 |
| 8 | 6 | 9 | 7 | 7 | 6 | 13 | 14 | 11 | 7 | 11 | 16 |
Operating Profit Operating ProfitCr |
| 7.6 | 9.6 | 6.2 | 13.6 | 12.0 | 11.0 | 4.8 | 9.3 | 7.8 | 10.1 | 8.3 | 8.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 20.5 | 142.1 | 12.5 | 45.6 | 38.3 | 15.2 | -6.7 | 49.3 | 3.1 | 18.9 | 69.0 | 42.0 |
| 5.2 | 6.5 | 4.6 | 8.2 | 8.2 | 7.6 | 3.1 | 6.4 | 5.5 | 7.8 | 5.9 | 8.1 |
| 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | 0.4 | 0.3 | 0.7 | 0.5 | 0.4 | 0.5 | 0.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 137.8 | -46.2 | -54.0 | -13.0 | -11.3 | -1.1 | 160.0 | -7.6 | 3.3 | 25.7 | 46.2 | 3.4 |
| 48 | 26 | 12 | 10 | 9 | 9 | 25 | 23 | 24 | 30 | 44 | 46 |
Operating Profit Operating ProfitCr |
| 14.4 | 13.0 | 16.7 | 18.2 | 19.3 | 18.7 | 8.0 | 9.6 | 9.1 | 10.1 | 7.9 | 8.5 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 7 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 |
| 2 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
|
| 229.9 | -58.5 | -38.3 | 0.6 | -1.3 | -4.5 | 18.0 | 7.3 | 1.4 | 46.2 | 17.6 | 30.6 |
| 8.8 | 6.8 | 9.1 | 10.5 | 11.7 | 11.3 | 5.1 | 5.9 | 5.8 | 6.8 | 5.4 | 6.9 |
| 3.3 | 1.4 | 0.8 | 0.8 | 0.6 | 0.8 | 0.9 | 1.0 | 1.0 | 1.5 | 1.8 | 2.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 10 | 10 | 10 | 10 | 10 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| 5 | 5 | 7 | 7 | 7 | 2 | 2 | 3 | 3 | 4 | 6 | 7 |
Current Liabilities Current LiabilitiesCr | 14 | 4 | 5 | 4 | 7 | 6 | 10 | 7 | 2 | 1 | 0 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 28 | 20 | 22 | 20 | 24 | 23 | 27 | 26 | 18 | 17 | 18 | 20 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 3 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -6 | 10 | -2 | 3 | -1 | 2 | -3 | 5 | 8 | 4 | 8 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | 0 |
Financing Cash Flow Financing Cash FlowCr | 6 | -10 | 1 | -3 | 2 | -2 | 3 | -3 | -8 | -4 | -2 |
|
Free Cash Flow Free Cash FlowCr | -6 | 10 | -2 | 3 | -1 | 1 | -3 | 4 | 7 | 3 | 7 |
| -120.1 | 496.1 | -123.0 | 253.7 | -113.3 | 126.3 | -185.0 | 328.1 | 505.0 | 186.6 | 286.6 |
CFO To EBITDA CFO To EBITDA% | -72.7 | 257.9 | -66.6 | 145.8 | -68.5 | 75.9 | -118.2 | 202.3 | 324.2 | 125.0 | 197.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 293 | 122 | 77 | 63 | 76 | 96 | 41 | 121 | 118 | 228 | 246 |
Price To Earnings Price To Earnings | 62.3 | 66.7 | 61.6 | 49.6 | 60.6 | 81.3 | 28.8 | 80.5 | 77.0 | 102.1 | 93.5 |
Price To Sales Price To Sales | 5.2 | 4.0 | 5.6 | 5.2 | 7.1 | 9.1 | 1.5 | 4.8 | 4.5 | 6.9 | 5.1 |
Price To Book Price To Book | 20.0 | 7.9 | 4.6 | 3.7 | 4.5 | 5.7 | 2.3 | 6.6 | 6.5 | 12.0 | 11.8 |
| 37.4 | 31.8 | 35.3 | 29.9 | 39.7 | 51.6 | 23.0 | 52.2 | 50.5 | 68.6 | 62.8 |
Profitability Ratios Profitability Ratios |
| 15.1 | 15.1 | 22.1 | 26.1 | 28.5 | 33.1 | 12.7 | 15.4 | 17.3 | 16.4 | 13.1 |
| 14.4 | 13.0 | 16.7 | 18.2 | 19.3 | 18.7 | 8.0 | 9.6 | 9.1 | 10.1 | 7.9 |
| 8.8 | 6.8 | 9.1 | 10.5 | 11.7 | 11.3 | 5.1 | 5.9 | 5.8 | 6.8 | 5.4 |
| 32.8 | 20.8 | 10.4 | 10.5 | 8.5 | 8.5 | 7.9 | 9.0 | 11.2 | 17.1 | 17.9 |
| 33.5 | 13.2 | 7.5 | 7.5 | 7.4 | 7.1 | 8.1 | 8.3 | 8.4 | 11.8 | 12.6 |
| 17.4 | 10.3 | 5.7 | 6.2 | 5.3 | 5.2 | 5.1 | 5.6 | 7.3 | 11.3 | 12.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Radix Industries (India) Limited is a prominent Indian public limited company specializing in the **manufacturing, processing, and global distribution of human hair products**. Headquartered in **Andhra Pradesh**, the company leverages India’s status as a premier source of high-quality human hair to serve a diverse international clientele across the fashion, beauty, and medical sectors.
---
### **Core Business Operations & Integrated Manufacturing**
The company operates within a single reportable business segment: the processing and sale of **Human Hair**. Radix Industries manages a sophisticated, integrated value chain from its primary facility to international retail markets.
* **Integrated Production Facility:** Operations are centralized at a specialized plant in **Tanuku, West Godavari District, Andhra Pradesh**. This location provides strategic access to raw material sourcing and logistical infrastructure.
* **Product Specialization:** The portfolio is centered on **human hair wigs and extensions**. Unlike synthetic alternatives, these products are prized for their **authentic appearance**, durability, and ability to be **heat-styled and colored**.
* **Global Export Footprint:** The company is an export-oriented entity, with a strategic focus on high-demand regions including **North America, Europe, and Sub-Saharan Africa**. Key specific markets include **China, Brazil, Spain, South Korea, and the United Kingdom**.
* **Risk Mitigation:** To manage the volatility of international trade, the company actively utilizes **forward contracts** to hedge against **foreign exchange risk** associated with export receivables.
---
### **Strategic Product Portfolio & Market Positioning**
Radix Industries aligns its output with two primary consumer pillars: aesthetic enhancement and medical necessity.
#### **1. Hair Wigs and Extensions**
* **Human Hair Dominance:** This remains the primary growth driver. The company positions these as **sustainable and eco-friendly** alternatives to "fast fashion" synthetic fibers.
* **Medical Applications:** Products are engineered for consumers experiencing **alopecia, pattern baldness, chemotherapy-induced hair loss, and postpartum shedding**.
* **Fashion & Aesthetics:** Catering to the "celebrity-driven" trend, the company provides volume-enhancing extensions and full-coverage wigs for the global beauty market.
#### **2. Organic and Natural Hair Care Expansion**
The company has diversified into the **clean-label** personal care space to complement its hardware (wigs) with software (topical care).
* **Clean-Label Formulations:** Focus on **vegan and chemical-free** shampoos, conditioners, and colorants.
* **Strategic Brand Synergy:** Through the **AVA Group**, the flagship brand **Medimix** launched the **Total Care Shampoo** in **May 2022**, targeting all hair types with natural ingredients.
* **R&D Investment:** Continuous capital allocation toward **Research and Development** ensures the company stays ahead of the shift toward **organic/natural** personal care.
---
### **Financial Performance & Shareholder Value**
Radix Industries has demonstrated a robust upward trajectory in both revenue and profitability, supported by disciplined corporate actions.
| Financial Metric (₹ in Lacs) | FY 2023-24 (Audited) | FY 2022-23 (Audited) | Growth (%) |
| :--- | :---: | :---: | :---: |
| **Total Revenue** | **3,313.17** | **2,626.92** | **+26.12%** |
| **Net Profit After Tax (PAT)** | **223.48** | **152.87** | **+46.19%** |
| **Dividend Per Share** | **-** | **₹1.00 (10%)** | **N/A** |
* **Recent Dividend:** For the fiscal year ended **March 31, 2025**, the Board recommended a dividend of **₹0.50 per equity share** (**5% payout** on a **Face Value of ₹10**).
* **Capital Structure:** As of **March 31, 2025**, **99.96%** of the paid-up share capital is held in **dematerialized form** (**ISIN: INE576N01014**).
* **Instruments:** The company has issued **zero** GDRs, ADRs, or convertible warrants, maintaining a clean equity structure.
---
### **Global Market Dynamics & Growth Strategy**
The global hair wigs and extensions market was valued at **USD 7.5 billion in 2024** and is projected to reach between **USD 12.6 billion and USD 15.5 billion by 2034**, with some long-term estimates reaching **USD 30.7 billion by 2032**.
**Strategic Growth Pillars:**
* **U.S. Market Penetration:** The company has approved the incorporation of a **Wholly Owned Subsidiary (WOS) in the United States** to establish a direct-to-market presence in the world’s largest consuming region.
* **Digital Transformation:** Integration of **e-commerce** platforms and **AI-powered virtual try-on tools** to enhance the consumer purchasing journey.
* **Sector CAGR:** Radix is positioned to capture a significant share of the industry's projected **8% to 10.2% CAGR**.
---
### **Leadership & Governance Framework**
The company is guided by a board with deep industrial and marketing expertise, recently reinforced by new appointments to ensure regulatory excellence.
| Name | Position | Tenure/Status |
| :--- | :--- | :--- |
| **Sri. G. Raghu Rama Raju** | Chairman & Managing Director | Re-appointed until **Aug 2026** |
| **Sri. G.G.R. Prabhakara Raju** | Director & CFO | Key Financial Oversight |
| **Sri. Rama Krishna Chilukuri** | Independent Director | Appointed **Aug 2025** |
| **Sri. K.S. Gaurav Tummala** | Company Secretary | Appointed **Aug 2025** |
| **M/s. Brahmayya and Co** | Statutory Auditors | 5-Year Term |
| **M/s. P S Rao & Associates** | Secretarial Auditor | Recommended for 5-Year Term |
---
### **Risk Profile & Mitigation Factors**
Investors should consider the following operational and macroeconomic headwinds:
* **Capital Intensity:** Raw hair cannot be sourced "just-in-time." This necessitates **bulk purchasing** and maintains high **inventory levels**, tying up significant **working capital**.
* **Medical Competition:** The rise of permanent solutions, such as **hair transplants** and pharmaceutical treatments (**Minoxidil, Finasteride**), competes with the wig segment.
* **Market Fragmentation:** The company faces stiff competition from the **unorganized sector** in India and other Asian processing hubs.
* **Macroeconomic Sensitivity:** Exposure to **sticky core inflation** and global **monetary policy tightening** may impact discretionary spending in Western markets.
* **Supply Chain Vulnerability:** Dependency on overseas markets makes the company sensitive to geopolitical shifts and international shipping costs.
### **Investment Summary**
Radix Industries (India) Limited offers a specialized play on the global beauty and medical aesthetics market. With a **46% YoY profit growth** in the last audited cycle, a clear **U.S. expansion strategy**, and a transition toward **clean-label hair care**, the company is evolving from a traditional processor into a diversified global hair solutions provider.